202 related articles for article (PubMed ID: 38355986)
21. Radiotherapy modification based on artificial intelligence and radiomics applied to (
Lucia F; Lovinfosse P; Schick U; Le Pennec R; Pradier O; Salaun PY; Hustinx R; Bourbonne V
Cancer Radiother; 2023 Sep; 27(6-7):542-547. PubMed ID: 37481344
[TBL] [Abstract][Full Text] [Related]
22. Single photon emission computed tomography for the diagnosis of coronary artery disease: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(8):1-64. PubMed ID: 23074411
[TBL] [Abstract][Full Text] [Related]
23. Artificial intelligence in single photon emission computed tomography (SPECT) imaging: a narrative review.
Shao W; Rowe SP; Du Y
Ann Transl Med; 2021 May; 9(9):820. PubMed ID: 34268433
[TBL] [Abstract][Full Text] [Related]
24. Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy.
Campbell F; Thokala P; Uttley LC; Sutton A; Sutton AJ; Al-Mohammad A; Thomas SM
Health Technol Assess; 2014 Sep; 18(59):1-120. PubMed ID: 25265259
[TBL] [Abstract][Full Text] [Related]
25. Applications of Artificial Intelligence in PSMA PET/CT for Prostate Cancer Imaging.
Lindgren Belal S; Frantz S; Minarik D; Enqvist O; Wikström E; Edenbrandt L; Trägårdh E
Semin Nucl Med; 2024 Jan; 54(1):141-149. PubMed ID: 37357026
[TBL] [Abstract][Full Text] [Related]
26. Clinical Applications of Artificial Intelligence in Positron Emission Tomography of Lung Cancer.
Zukotynski KA; Gaudet VC; Uribe CF; Chiam K; Bénard F; Gerbaudo VH
PET Clin; 2022 Jan; 17(1):77-84. PubMed ID: 34809872
[TBL] [Abstract][Full Text] [Related]
27. Artificial Intelligence-based Radiomics in the Era of Immuno-oncology.
Kang CY; Duarte SE; Kim HS; Kim E; Park J; Lee AD; Kim Y; Kim L; Cho S; Oh Y; Gim G; Park I; Lee D; Abazeed M; Velichko YS; Chae YK
Oncologist; 2022 Jun; 27(6):e471-e483. PubMed ID: 35348765
[TBL] [Abstract][Full Text] [Related]
28. Artificial Intelligence and Machine Learning in Predicting the Response to Immunotherapy in Non-small Cell Lung Carcinoma: A Systematic Review.
Sinha T; Khan A; Awan M; Bokhari SFH; Ali K; Amir M; Jadhav AN; Bakht D; Puli ST; Burhanuddin M
Cureus; 2024 May; 16(5):e61220. PubMed ID: 38939246
[TBL] [Abstract][Full Text] [Related]
29. Artificial Intelligence for the Characterization of Pulmonary Nodules, Lung Tumors and Mediastinal Nodes on PET/CT.
Krarup MMK; Krokos G; Subesinghe M; Nair A; Fischer BM
Semin Nucl Med; 2021 Mar; 51(2):143-156. PubMed ID: 33509371
[TBL] [Abstract][Full Text] [Related]
30. Empowering PET: harnessing deep learning for improved clinical insight.
Artesani A; Bruno A; Gelardi F; Chiti A
Eur Radiol Exp; 2024 Feb; 8(1):17. PubMed ID: 38321340
[TBL] [Abstract][Full Text] [Related]
31. Development of Radiomic-Based Model to Predict Clinical Outcomes in Non-Small Cell Lung Cancer Patients Treated with Immunotherapy.
Tankyevych O; Trousset F; Latappy C; Berraho M; Dutilh J; Tasu JP; Lamour C; Cheze Le Rest C
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497415
[TBL] [Abstract][Full Text] [Related]
32. [18F]FDG PET immunotherapy radiomics signature (iRADIOMICS) predicts response of non-small-cell lung cancer patients treated with pembrolizumab.
Valentinuzzi D; Vrankar M; Boc N; Ahac V; Zupancic Z; Unk M; Skalic K; Zagar I; Studen A; Simoncic U; Eickhoff J; Jeraj R
Radiol Oncol; 2020 Jul; 54(3):285-294. PubMed ID: 32726293
[TBL] [Abstract][Full Text] [Related]
33. Clinical application of deep learning and radiomics in hepatic disease imaging: a systematic scoping review.
Wang L; Zhang L; Jiang B; Zhao K; Zhang Y; Xie X
Br J Radiol; 2022 Aug; 95(1136):20211136. PubMed ID: 35816550
[TBL] [Abstract][Full Text] [Related]
34. Predicting PD-L1 expression status in patients with non-small cell lung cancer using [
Zhao X; Zhao Y; Zhang J; Zhang Z; Liu L; Zhao X
EJNMMI Res; 2023 Jan; 13(1):4. PubMed ID: 36682020
[TBL] [Abstract][Full Text] [Related]
35. Radiomics study for predicting the expression of PD-L1 in non-small cell lung cancer based on CT images and clinicopathologic features.
Sun Z; Hu S; Ge Y; Wang J; Duan S; Song J; Hu C; Li Y
J Xray Sci Technol; 2020; 28(3):449-459. PubMed ID: 32176676
[TBL] [Abstract][Full Text] [Related]
36. Imaging-Based Prediction of Molecular Therapy Targets in NSCLC by Radiogenomics and AI Approaches: A Systematic Review.
Ninatti G; Kirienko M; Neri E; Sollini M; Chiti A
Diagnostics (Basel); 2020 May; 10(6):. PubMed ID: 32486314
[TBL] [Abstract][Full Text] [Related]
37. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
38. Applications of artificial intelligence in oncologic
Sadaghiani MS; Rowe SP; Sheikhbahaei S
Ann Transl Med; 2021 May; 9(9):823. PubMed ID: 34268436
[TBL] [Abstract][Full Text] [Related]
39. Artificial intelligence-driven assessment of radiological images for COVID-19.
Bouchareb Y; Moradi Khaniabadi P; Al Kindi F; Al Dhuhli H; Shiri I; Zaidi H; Rahmim A
Comput Biol Med; 2021 Sep; 136():104665. PubMed ID: 34343890
[TBL] [Abstract][Full Text] [Related]
40. Artificial intelligence for molecular neuroimaging.
Boyle AJ; Gaudet VC; Black SE; Vasdev N; Rosa-Neto P; Zukotynski KA
Ann Transl Med; 2021 May; 9(9):822. PubMed ID: 34268435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
